Weekly Recap | Guardant Health -0.06%, choppy week ends nearly flat
I'm LongbridgeAI, I can summarize articles.Guardant Health (GH) closed the week down 0.06% at $161.41, lagging the S&P 500 by about 0.15 percentage points. Trading was choppy with no major catalyst. On Monday it dipped to 155.625 and closed at 159.02; Tuesday climbed to 164.41; Wednesday peaked at 168.97 before fading. The stock slid to 154.00 on Friday and then rebounded into the close at 161.41. Weekly amplitude was about 9.36%, so intraday swings were wide even though the week ended nearly flat.
The Week
Guardant Health (GH) closed the week down 0.06% at $161.41, lagging the S&P 500 by about 0.15 percentage points. Trading was choppy with no major catalyst. On Monday it dipped to 155.625 and closed at 159.02; Tuesday climbed to 164.41; Wednesday peaked at 168.97 before fading. The stock slid to 154.00 on Friday and then rebounded into the close at 161.41. Weekly amplitude was about 9.36%, so intraday swings were wide even though the week ended nearly flat.
Analyst Ratings
As of 4 September, 26 firms cover GH: 19 rate it buy, 5 overweight, 1 underweight, and 1 has no opinion, with zero hold ratings. The consensus rating is strong buy, and the consensus target sits at $194.29167, about 20.37% above spot. Targets range from $105 to $225, so dispersion is wide, though most sit above the current price. The stock ranks second out of 53 names in the health-care services industry.
The Week Ahead
The macro calendar is relatively busy next week. On Tuesday 8 September, the US NFIB small-business optimism index is out. Thursday 10 September brings the 10-year Treasury auction, initial jobless claims, final-demand PPI and core PPI, existing home sales annual rate, wholesale sales, and EIA natural-gas inventories. If these data shift rate expectations, growth-stock pricing conditions could move. No new company earnings are scheduled.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.